Cited by 2,820Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer and biochemical research

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

Christofk, Heather R., Vander Heiden, Matthew G., Harris, Marian H., Ramanathan, Arvind, Gerszten, Robert E., Wei, Ru, Fleming, Mark D., Schreiber, Stuart L., Cantley, Lewis C.·2008·Nature

DOI 10.1038/nature06734

Open this paper in CoChat — free account

Abstract

Many tumour cells have elevated rates of glucose uptake but reduced rates of oxidative phosphorylation. This persistence of high lactate production by tumours in the presence of oxygen, known as aerobic glycolysis, was first noted by Otto Warburg more than 75 yr ago. How tumour cells establish this altered metabolic phenotype and whether it is essential for tumorigenesis is as yet unknown. Here we show that a single switch in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular metabolism to aerobic glycolysis and that this promotes tumorigenesis. Tumour cells have been shown to express exclusively the embryonic M2 isoform of pyruvate kinase. Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines and replace it with pyruvate kinase M1. Switching pyruvate kinase expression to the M1 (adult) isoform leads to reversal of the Warburg effect, as judged by reduced lactate production and increased oxygen consumption, and this correlates with a reduced ability to form tumours in nude mouse xenografts. These results demonstrate that M2 expression is necessary for aerobic glycolysis and that this metabolic phenotype provides a selective growth advantage for tumour cells in vivo.

Integrity signals

Registry

Crossref · 10.1038/nature06734

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.
Muller, W., Sinn, E., Pattengale, P., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,246
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
Self-citation
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 662
Growth factors can influence cell growth and survival through effects on glucose metabolism
Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5899-5912.2001 · Cited by 536
Self-citation

Show all 20 references

Sorted by citations

Items 801–900 of 1,008

PKM2: A Potential Regulator of Rheumatoid Arthritis via Glycolytic and Non-Glycolytic Pathways
Xu, D., Liang, J., Lin, J., & Yu, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02919 · Cited by 77
Regulation of Yeast Pyruvate Kinase by Ultrasensitive Allostery Independent of Phosphorylation
Xu, Y. F., Zhao, X., Glass, D. S., Absalan, F., Perlman, D. H., Broach, J. R., & Rabinowitz, J. D. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.013 · Cited by 77
Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo
Meng, M.-B., Wang, H.-H., Guo, W.-H., Wu, Z.-Q., Zeng, X.-L., Zaorsky, N. G., Shi, H., Qian, D., Niu, Z.-M., Jiang, B., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.016 · Cited by 77
The SUMO‐E3 ligase PIAS3 targets pyruvate kinase M2
Spoden, G. A., Morandell, D., Ehehalt, D., Fiedler, M., Jansen‐Dürr, P., Hermann, M., & Zwerschke, W. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22125 · Cited by 77
Translational Control of Mitochondrial Energy Production Mediates Neuron Morphogenesis
Oruganty-Das, A., Ng, T., Udagawa, T., Goh, E. L. K., & Richter, J. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.002 · Cited by 77
CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma
Shang, Y., He, J., Wang, Y., Feng, Q., Zhang, Y., Guo, J., Li, J., Li, S., Wang, Y., Yan, G., et al. (2017) · Oncogene · doi:10.1038/onc.2017.31 · Cited by 77
Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer
Wang, X., Xie, J., & Proud, C. G. (2017) · Cancers · doi:10.3390/cancers9120162 · Cited by 77
Interplay between cancer cell cycle and metabolism: Challenges, targets and therapeutic opportunities
Roy, D., Sheng, G. Y., Semukunzi, H., de Carvalho, E. L., Mahanty, A., Yuan, S., & Sun, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.019 · Cited by 76
Mechanism of PKM2 affecting cancer immunity and metabolism in Tumor Microenvironment
Chen, M., Liu, H., Li, Z., Ming, A. L., & Chen, H. (2021) · Journal of Cancer · doi:10.7150/jca.54430 · Cited by 76
MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
Teng, Y., Zhang, Y., Qu, K., Yang, X., Fu, J., Chen, W., & Li, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5695 · Cited by 76
Tumor Microenvironment and Metabolism in Prostate Cancer
Chiarugi, P., Paoli, P., & Cirri, P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.004 · Cited by 76
ATP synthase c-subunit ring as the channel of mitochondrial permeability transition: Regulator of metabolism in development and degeneration
Mnatsakanyan, N., & Jonas, E. A. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.05.013 · Cited by 76
MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers
Pinweha, P., Rattanapornsompong, K., Charoensawan, V., & Jitrapakdee, S. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.05.005 · Cited by 75
Role of pyruvate kinase M2 in oxidized LDL-induced macrophage foam cell formation and inflammation
Kumar, A., Gupta, P., Rana, M., Chandra, T., Dikshit, M., & Barthwal, M. K. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000382 · Cited by 75
Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma
Chen, Z., Lu, X., Wang, Z., Jin, G., Wang, Q., Chen, D., Chen, T., Li, J., Fan, J., Cong, W., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2991 · Cited by 75
Regulation of Cellular Metabolism by High-Risk Human Papillomaviruses
Martínez-Ramírez, I., Carrillo‐García, A., Contreras‐Paredes, A., Ortíz-Sánchez, E., Cruz‐Gregorio, A., & Lizano, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071839 · Cited by 75
Glucose addiction in cancer therapy: advances and drawbacks
Granja, S., Pinheiro, C. M., Reis, R. M., Martinho, O., & Baltazar, F. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150602145145 · Cited by 74
PKM2: A gatekeeper between growth and survival
Harris, I. S., McCracken, S. A., & Mak, T. W. (2011) · Cell Research · doi:10.1038/cr.2011.203 · Cited by 74
Significance of Polypyrimidine Tract–Binding Protein 1 Expression in Colorectal Cancer
Takahashi, H., Nishimura, J., Kagawa, Y., Kano, Y., Takahashi, Y., Wu, X., Hiraki, M., Hamabe, A., Konno, M., Haraguchi, N., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0142 · Cited by 74
Mitochondrial determinants of cancer health disparities
Choudhury, A. R., & Singh, K. K. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.001 · Cited by 75
Why cancer cells have a more hyperpolarised mitochondrial membrane potential and emergent prospects for therapyPreprint
Forrest, M. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/025197 · Cited by 74
Tumor Metabolism of Malignant Gliomas
Ru, P., Williams, T. M., Chakravarti, A., & Guo, D. (2013) · Cancers · doi:10.3390/cancers5041469 · Cited by 73
Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells
Sazeides, C., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_11 · Cited by 73
Peptide‐Appended Nanosonosensitizers Targeting Tumor Glycolysis for Synergistic Sonodynamic–Immunometabolic Therapy of Spinal‐Metastasized Tumors
Chen, Z., Chen, L., Ma, Y., Liu, Y., Zhang, Q., Qin, H., Chen, Y., Tian, B., & Dong, J. (2023) · Advanced Materials · doi:10.1002/adma.202304246 · Cited by 73
The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications
Jiang, X., Sun, Q., Li, H., Li, K., & Ren, X. (2013) · International Journal of Cancer · doi:10.1002/ijc.28637 · Cited by 73
PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer
Seo, M., & Lee, Y. H. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.11.021 · Cited by 73
Identification of Novel Alternative Splice Isoforms of Circulating Proteins in a Mouse Model of Human Pancreatic Cancer
Menon, R., Zhang, Q. H., Zhang, Y., Fermin, D., Bardeesy, N. M., DePinho, R. A., Lü, C., Hanash, S., Omenn, G. S., & States, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2145 · Cited by 73
Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth
Parnell, K. M., Foulks, J. M., Nix, R. N., Clifford, A., Bullough, J., LUO, B. H., Senina, A. V., Vollmer, D., Liu, J., McCarthy, V., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0026 · Cited by 73
Changes in Pyruvate Metabolism Detected by Magnetic Resonance Imaging Are Linked to DNA Damage and Serve as a Sensor of Temozolomide Response in Glioblastoma Cells
Park, I., Mukherjee, J., Ito, M., Chaumeil, M. M., Jalbert, L. E., Gaensler, K. M. L., Ronen, S. M., Nelson, S. J., & Pieper, R. O. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0849 · Cited by 73
FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription
Wang, Y., Yun, Y., Wu, B., Wen, L., Wen, M., Yang, H., Zhao, L., Liu, W., Huang, S., Wen, N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10103 · Cited by 73
Antioxidant Activity during Tumor Progression: A Necessity for the Survival of Cancer Cells?
Hawk, M. A., McCallister, C. M., & Schafer, Z. T. (2016) · Cancers · doi:10.3390/cancers8100092 · Cited by 73
iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer
Li, L., Zhu, L., Hao, B., Gao, W., Wang, Q., Li, K., Wang, M., Huang, M., Liu, Z., Yang, Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16523 · Cited by 73
Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect
Singh, S., Narayanan, S. P., Biswas, K., Gupta, A., Ahuja, N., Yadav, S., Panday, R. K., Samaiya, A., Sharan, S. K., & Shukla, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708447114 · Cited by 73
PKM2-dependent metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis
Lü, S., Deng, J., Liu, H., Liu, B., Yang, J., Miao, Y., Li, J., Wang, N., Jiang, C., Xu, Q., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1645-6 · Cited by 73
SIRT5 deficiency suppresses mitochondrial ATP production and promotes AMPK activation in response to energy stress
Zhang, M., Wu, J., Sun, R., Tao, X., Wang, X., Kang, Q., Wang, H., Zhang, L., Liu, P., Zhang, J., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0211796 · Cited by 72
AMPK regulates immunometabolism in sepsis
Huang, J. X., Liu, K., Zhu, S., Xie, M., Kang, R., Cao, L., & Tang, D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.003 · Cited by 72
Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-kB Activity in Triple-Negative Breast Cancer Cells.
Ma, C., Zu, X., Liu, K., Bode, A. M., Dong, Z., Liu, Z., & Kim, D. J. (2019) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2019.0038 · Cited by 72
TPP-based mitocans: a potent strategy for anticancer drug design
Wang, J., Li, J., Xiao, Y., Fu, B., & Qin, Z. (2020) · RSC Medicinal Chemistry · doi:10.1039/c9md00572b · Cited by 72
Investigational cancer drugs targeting cell metabolism in clinical development
Sborov, D. W., Haverkos, B. M., & Harris, P. J. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.960077 · Cited by 72
Expression Profiling in Progressive Stages of Fumarate-Hydratase Deficiency: The Contribution of Metabolic Changes to Tumorigenesis
Ashrafian, H., O′Flaherty, L., Adam, J., Steeples, V., Chung, Y., East, P., Vanharanta, S., Lehtonen, H. J., Nye, E. L., Hatipoglu, E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1949 · Cited by 72
N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation
Granchi, C., Roy, S., Simone, A. D., Salvetti, I., Tuccinardi, T., Martinelli, A., Macchia, M., Lanza, M., Betti, L., Giannaccini, G., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.08.046 · Cited by 72
In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
Khurshed, M., Molenaar, R. J., Lenting, K., Leenders, W. P. J., & Noorden, C. J. F. V. (2017) · Oncotarget · doi:10.18632/oncotarget.17106 · Cited by 72
Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
Jia, R., Ajiro, M., Yu, L., McCoy, P. J., & Zheng, Z. (2019) · RNA · doi:10.1261/rna.068619.118 · Cited by 72
Cancer stem cells: a potential target for cancer therapy
Qiu, H. Y., Fang, X., Luo, Q., & Ouyang, G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1920-4 · Cited by 72
Effects of different doses of X‑ray irradiation on cell apoptosis, cell cycle, DNA damage repair and glycolysis in HeLa cells
Zhao, H. G., Zhuang, Y., Li, R., Liu, Y., Mei, Z., He, Z., Zhou, F., & Zhou, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9566 · Cited by 71
Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling
Shahid, M., Lee, M. Y., Piplani, H., Andres, A. M., Zhou, B., Yeon, A., Kim, M., Kim, H. L., & Kim, J. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1557496 · Cited by 71
The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
Cerasuolo, A., Buonaguro, L., Buonaguro, L., & Tornesello, M. L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00474 · Cited by 71
Splicing in oncogenesis and tumor suppression
Kaida, D., Schneider‐Poetsch, T., & Yoshida, M. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02356.x · Cited by 71
Aberrant Overexpression of Pyruvate Kinase M2 Is Associated With Aggressive Tumor Features and the BRAF Mutation in Papillary Thyroid Cancer
Feng, C., Gao, Y. L., Wang, C., Yu, X., Zhang, W., Guan, H., Shan, Z., & Teng, W. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4258 · Cited by 71
mTORC2 controls cancer cell survival by modulating gluconeogenesis
Khan, M. W., Biswas, D., Ghosh, M., Mandloi, S., Chakrabarti, S., & Chakrabarti, P. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.16 · Cited by 71
Hepatitis C virus infection triggers a tumor‐like glutamine metabolism
Levy, P. L., Duponchel, S., Eischeid, H., Molle, J., Michelet, M., Diserens, G., Vermathen, M., Vermathen, P., Dufour, J., Dienes, H., et al. (2016) · Hepatology · doi:10.1002/hep.28949 · Cited by 71
“Omics” in oral cancer: New approaches for biomarker discovery
Rai, V., Mukherjee, R., Ghosh, A. K., Routray, A., & Chakraborty, C. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.12.003 · Cited by 71
Rewiring of embryonic glucose metabolism via suppression of PFK-1 and aldolase during mouse chorioallantoic branching
Miyazawa, H., Yamaguchi, Y., Sugiura, Y., Honda, K., Kondo, K., Matsuda, F., Yamamoto, T., Suematsu, M., & Miura, M. (2017) · Development · doi:10.1242/dev.138545 · Cited by 71
Metabolic signatures of human breast cancer
Mishra, P., & Ambs, S. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.992217 · Cited by 70
PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis
Zhao, X., Tan, F., Cao, X., Cao, Z., Li, B., Shen, Z., & Tian, Y. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz135 · Cited by 70
Metabolic heterogeneity in cancer: An overview and therapeutic implications
Yu, T., Gao, W., & Liu, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188421 · Cited by 70
Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches
Fernandes, P. M., Kinkead, J., McNae, I. W., Michels, P. A. M., & Walkinshaw, M. D. (2020) · Biochemical Journal · doi:10.1042/bcj20200656 · Cited by 70
The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma
Xu, F., Guan, Y., Li, X., Huang, S., Gao, K., Yang, Z., & Chong, T. (2020) · BMC Cancer · doi:10.1186/s12885-020-07702-7 · Cited by 70
HIF-1α Metabolic Pathways in Human Cancer
Elzakra, N., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51652-9_17 · Cited by 72
Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors
Sun, X., Peng, Y., Zhao, J., Xie, Z., Lei, X., & Tang, G. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104891 · Cited by 70
Metabolic reprogramming in colorectal cancer: regulatory networks and therapy
Zhang, J., Zou, S., & Fang, L. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00977-w · Cited by 73
LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative splicing of PKM
Bian, Z., Yang, F., Xu, P., Gao, G., Yang, C., Cao, Y., Yao, S., Wang, X., Yin, Y., Fei, B., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01939-7 · Cited by 70
Enzymatic features of the glucose metabolism in tumor cells
Herling, A., König, M., Bulik, S., & Holzhütter, H. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08174.x · Cited by 70
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis
Cordani, M., Pacchiana, R., Butera, G., D’Orazi, G., Scarpa, A., & Donadelli, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.046 · Cited by 70
An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing Glycolysis
Zhu, Y., da Silva, S. R., He, M., Liang, Q., Lu, C., Feng, P., Jung, J. U., & Gao, S. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005648 · Cited by 70
Homocysteine Activates B Cells via Regulating PKM2-Dependent Metabolic Reprogramming
Deng, J., Lü, S., Liu, H., Liu, B., Jiang, C., Xu, Q., Feng, J., & Wang, X. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600613 · Cited by 70
Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein
Cheng, T., Yang, Y., Wang, H., Tien, Y., Shun, C., Huang, H., Hsiao, M., & Hua, K. (2018) · Oncogene · doi:10.1038/s41388-017-0086-y · Cited by 70
An allostatic mechanism for M2 pyruvate kinase as an amino-acid sensor
Yuan, M., McNae, I. W., Chen, Y., Blackburn, E. A., Wear, M. A., Michels, P. A. M., Fothergill‐Gilmore, L. A., Hupp, T. R., & Walkinshaw, M. D. (2018) · Biochemical Journal · doi:10.1042/bcj20180171 · Cited by 70
Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer
Lee, Y. G., Nam, Y., Shin, K. J., Yoon, S., Park, W. S., Joung, J. Y., Seo, J. K., Jang, J., Lee, S., Nam, D., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.017 · Cited by 70
Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis
Dong, W., Keibler, M. A., & Stephanopoulos, G. N. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.02.002 · Cited by 69
Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer
Wu, D., Dasgupta, A., Read, A. D., Bentley, R. E. T., Motamed, M., Chen, K., Al‐Qazazi, R., Mewburn, J. D., Dunham‐Snary, K. J., Alizadeh, E., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.452 · Cited by 69
Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells
Kim, D. J., Park, Y. S., Kang, M., You, Y.-M., Jung, Y., Koo, H., Kim, J., Kim, M., Hong, S., Lee, K. B., et al. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.05.017 · Cited by 69
Conformational Switching in Pyruvic Acid Isolated in Ar and N 2 Matrixes: Spectroscopic Analysis, Anharmonic Simulation, and Tunneling
Reva, I. D., Nunes, C. M., Biczysko, M., & Fausto, R. (2014) · The Journal of Physical Chemistry A · doi:10.1021/jp509578c · Cited by 69
Mutually exclusive alternative splicing of pre‐mRNAs
Jin, Y., Dong, H., Shi, Y., & Bian, L. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1468 · Cited by 69
Nitric oxide maintains endothelial redox homeostasis through PKM2 inhibition
Siragusa, M., Thoele, J., Bibli, S., Luck, B., Loot, A. E., de Silva, K., Wittig, I., Heidler, J., Stingl, H., Randriamboavonjy, V., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100938 · Cited by 69
PFKFB3 inhibitors as potential anticancer agents: Mechanisms of action, current developments, and structure-activity relationships
Wang, Y., Qu, C., Liu, T., & Wang, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112612 · Cited by 69
Changes in Global Gene Expression Associated with 3D Structure of Tumors: An Ex Vivo Matrix-Free Mesothelioma Spheroid Model
Kim, H., Phung, Y., & Ho, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039556 · Cited by 68
Aerobic Glycolysis in the Retina: Functional Roles of Pyruvate Kinase Isoforms
Rajala, R. V. S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00266 · Cited by 68
Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development
Gao, L., Yang, F., Tang, D., Xu, Z., Tang, Y., Yang, D., Sun, D., Chen, Z., & Teng, Y. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02574-0 · Cited by 68
Reciprocal Regulation of Protein Kinase and Pyruvate Kinase Activities of Pyruvate Kinase M2 by Growth Signals
Gao, X., Wang, H., Yang, J. J., Chen, J., Jie, J., Li, L., Zhang, Y., & Liu, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448753 · Cited by 68
l -cysteine reversibly inhibits glucose-induced biphasic insulin secretion and ATP production by inactivating PKM2
Nakatsu, D., Horiuchi, Y., Kano, F., Noguchi, Y., Sugawara, T., Takamoto, I., Kubota, N., Kadowaki, T., & Murata, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417197112 · Cited by 68
Six Hours after Infection, the Metabolic Changes Induced by WSSV Neutralize the Host’s Oxidative Stress Defenses
Chen, I.-T., Lee, D., Huang, Y., Kou, G., Wang, H., Chang, G., & Lo, C. (2016) · Scientific Reports · doi:10.1038/srep27732 · Cited by 68
PKM2 promotes glucose metabolism through a let‐7a‐5p/Stat3/hnRNP‐A1 regulatory feedback loop in breast cancer cells
Yao, A., Xiang, Y., Si, Y., Fan, L., Li, J., Li, H., Guo, W., He, H., Liang, X., Tan, Y., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27947 · Cited by 68
Regulation of Autophagy by Glycolysis in Cancer
Chu, Y., Chang, Y., Lü, W., Sheng, X., Wang, S., Xu, H., & Ma, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s279672 · Cited by 68
Cancer metabolism and intervention therapy
Zhao, H., & Li, Y. (2021) · Molecular Biomedicine · doi:10.1186/s43556-020-00012-1 · Cited by 67
Enzymatic activation of pyruvate kinase increases cytosolic oxaloacetate to inhibit the Warburg effect
Wiese, E. K., Hitosugi, S., Loa, S. T., Sreedhar, A., Andres‐Beck, L. G., Kurmi, K., Pang, Y., Karnitz, L. M., Gonsalves, W. I., & Hitosugi, T. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00424-5 · Cited by 67
Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components
Bahar, E., Han, S., Kim, J., & Yoon, H. (2022) · Cancers · doi:10.3390/cancers14061462 · Cited by 67
Biocatalytic Depletion of Tumorigenic Energy Sources Driven by Cascade Reactions for Efficient Antitumor Therapy
Xiao, Y., Chen, P., Lei, S., Bai, F., Fu, L., Lin, J., & Huang, P. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204584 · Cited by 67
The Warburg effect on radioresistance: Survival beyond growth
Kang, H., Kim, B., Park, J., Youn, H., & Youn, B. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188988 · Cited by 67
Functional Inhibition of Aquaporin‐3 With a Gold‐Based Compound Induces Blockage of Cell Proliferation
Serna‐Gallego, A., Galán‐Cobo, A., Rodrigues, C., Sánchez-Gomar, I., Toledo‐Aral, J. J., Moura, T. F., Casini, A., Soveral, G., & Echevarrı́a, M. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24632 · Cited by 67
PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2
Witney, T. H., James, M. L., Shen, B., Chang, E., Pohling, C., Arksey, N., Höhne, A., Shuhendler, A. J., Park, J. H., Bodapati, D., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6117 · Cited by 67
Oxysterols in cancer cell proliferation and death
de Weille, J. R., Fabre, C., & Bakalara, N. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.029 · Cited by 67
Decrypting the genome's alternative messages
Hartmann, B., & Valcárcel, J. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.02.006 · Cited by 67
Proteomic Cornerstones of Hematopoietic Stem Cell Differentiation: Distinct Signatures of Multipotent Progenitors and Myeloid Committed Cells
Klimmeck, D., Hansson, J., Raffel, S., Vakhrushev, S. Y., Trumpp, A., & Krijgsveld, J. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016790 · Cited by 67
PKM2 Tyrosine Phosphorylation and Glutamine Metabolism Signal a Different View of the Warburg Effect
Dang, C. V. (2009) · Science Signaling · doi:10.1126/scisignal.297pe75 · Cited by 67
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development
Soncini, M., Corna, G., Moresco, M. A., Coltella, N., Restuccia, U., Maggioni, D., Raccosta, L., Lin, C., Invernizzi, F., Crocchiolo, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613332113 · Cited by 69
Deciphering metabolic rewiring in breast cancer subtypes
Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 67
Metabolic Reprogramming in Thyroid Carcinoma
Coelho, R. G., Fortunato, R. S., & de Carvalho, D. P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00082 · Cited by 67
Rhabdomyosarcoma cells show an energy producing anabolic metabolic phenotype compared with primary myocytes
Fan, T. W. ‐., Kucia, M., Jankowski, K., Higashi, R. M., Ratajczak, J., Ratajczak, M. Z., & Lane, A. N. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-79 · Cited by 67
Glioblastoma Metabolism: Insights and Therapeutic Strategies
Bernhard, C., Reita, D., Martin, S., Entz‐Werlé, N., & Dontenwill, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119137 · Cited by 66

Authors: Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C.
Affiliations: Harvard University (US)
Boston Children's Hospital (US)
Broad Institute (US)
Beth Israel Deaconess Medical Center (US)
Corresponding author: Cantley, Lewis C.
ORCID: Christofk, Heather R.
Harris, Marian H.
Ramanathan, Arvind
Gerszten, Robert E.
Wei, Ru
Fleming, Mark D.
Schreiber, Stuart L.
Cantley, Lewis C.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2008-03
Volume: 452
Issue: 7184
Pages: 230-233
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature06734
OpenAlex: W2015207840
Cited by: 2,820
References: 20
Citations by year: 2026: 68 · 2025: 101 · 2024: 133 · 2023: 142 · 2022: 151 · 2021: 174 · 2020: 169 · 2019: 170 · 2018: 190 · 2017: 158 · 2016: 180 · 2015: 204 · 2014: 211 · 2013: 187 · 2012: 186
FWCI: 44.09
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Howard Hughes Medical Institute
National Cancer Institute (T32CA009172)
National Institute of General Medical Sciences (R01GM056203)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
Keywords: PKM2, alternative splicing, cancer metabolism, Warburg effect, aerobic glycolysis, carcinogenesis, phosphotyrosine binding, lactic acid production, oxygen consumption, glucose uptake, oxidative phosphorylation, tumor growth, glycolysis, tumor cell proliferation, tumor hypoxia
MeSH terms: Animals, Fructosediphosphates, Glycolysis, Humans, Lung Neoplasms, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Oxidative Phosphorylation, Oxygen Consumption, Pyruvate Kinase, Gene Expression Regulation, Neoplastic, Alternative Splicing, Pyruvic Acid, Lactic Acid, Cell Line, Tumor, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks